SCHEMBL3955052

SCHEMBL3955052

CN(C(=O)n1ccnc1)c1ccc(Cl)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.40
MAPT P10636 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
FSCN1 Q16658 1/20 0.38
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
IDO1 P14902 2/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
GPBAR1 Q8TDU6 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
PROKR1 Q8TCW9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11538337 0.87 FSCN1 (0.54) AHRMAPTFSCN1THRBIDO1
Iodide SCHEMBL3955556 0.75 LMNA (0.43) SIRT2FSCN1THRBKMT2APROKR1
SCHEMBL11542419 0.74 AHR (0.50) AHRMAPTFSCN1THRBCYP3A4
SCHEMBL3883604 0.73 FSCN1 (0.50) MAPTSIRT2FSCN1KMT2APSEN1
SCHEMBL11540763 0.72 AHR (0.56) AHRMAPTFSCN1THRBKMT2A
SCHEMBL11540118 0.70 AHR (0.46) AHRMAPTTHRBKMT2APSEN1
SCHEMBL11540399 0.70 AHR (0.51) AHRMAPTFSCN1THRBPSEN1
SCHEMBL19691848 0.69 ALDH1A1 (0.50) AHRMAPTCYP3A4CYP2D6
SCHEMBL14387302 0.69 FSCN1 (0.38) SIRT2FSCN1KMT2AIDO1PROKR1
SCHEMBL11541542 0.69 MAPT (0.45) AHRMAPTKMT2AIDO1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013163-A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE 1 Incyte Corporation (US) 2009-01-14 EP disclosed
US-20070293529-A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 INCYTE CORPORATION 2007-12-20 US disclosed
WO-2007130898-A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 INCYTE CORPORATION (US) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293529-A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD17B11 AHR 2026/4885MAPT 1541/4885SIRT2 2871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.